Glassman Wealth Services’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-4
Closed -$438 542
2023
Q4
$438 Hold
4
﹤0.01% 1749
2023
Q3
$403 Hold
4
﹤0.01% 1777
2023
Q2
$544 Hold
4
﹤0.01% 1622
2023
Q1
$415 Hold
4
﹤0.01% 1653
2022
Q4
$355 Hold
4
﹤0.01% 1690
2022
Q3
$0 Sell
4
-5
-56% -$472 ﹤0.01% 1709
2022
Q2
$1K Sell
9
-1
-10% -$120 ﹤0.01% 1372
2022
Q1
$1K Hold
10
﹤0.01% 1358
2021
Q4
$1K Buy
10
+6
+150% +$850 ﹤0.01% 1337
2021
Q3
$1K Hold
4
﹤0.01% 1310
2021
Q2
$1K Hold
4
﹤0.01% 1256
2021
Q1
$1K Hold
4
﹤0.01% 1219
2020
Q4
$0 Hold
4
﹤0.01% 1374
2020
Q3
$0 Hold
4
﹤0.01% 1342
2020
Q2
$0 Hold
4
﹤0.01% 1265
2020
Q1
$0 Sell
4
-2
-33% -$184 ﹤0.01% 1193
2019
Q4
$1K Buy
6
+3
+100% +$320 ﹤0.01% 880
2019
Q3
$0 Hold
3
﹤0.01% 1096
2019
Q2
$0 Hold
3
﹤0.01% 1121
2019
Q1
$0 Buy
+3
New +$218 ﹤0.01% 1062

Other funds holding CNMD

Glassman Wealth Services's CNMD Position: Q1 2024 in Review

Glassman Wealth Services sold out of CONMED (CNMD) in Q1 2024, closing a stake of 4 shares — an estimated $438 sold.

Glassman Wealth Services first reported a position in CNMD in Q1 2019 and held it in 20 quarters. The position peaked at $1K in Q2 2022. 298 funds tracked by Wall St. Rank hold CNMD as of Q1 2024.

  • Glassman Wealth Services reported no remaining CONMED position as of Q1 2024 after selling out during the quarter.
  • Glassman Wealth Services sold 4 CONMED shares in Q1 2024, an estimated $438.
  • Glassman Wealth Services first reported a position in CONMED in Q1 2019 and held it in 20 quarters.
  • Glassman Wealth Services's CONMED position peaked at $1K in Q2 2022.
  • 298 funds tracked by Wall St. Rank held CONMED as of Q1 2024.

Based on Glassman Wealth Services's 13F filing for Q1 2024, filed 3 May 2024.